[The cytokine system of bone tissue].
Stilgren
Lis Saalbach
LS
Odense Universitetshospital, Medicinsk Afdeling C.
Abrahamsen
Bo
B
Abdallah
Basem M
BM
Jørgensen
Niklas Rye
NR
D001851:Bone Diseases, Metabolic / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism; D016723:Bone Remodeling / Q000187:drug effects / Q000276:immunology / Q000502:physiology; D001862:Bone Resorption / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism; D001842:Bone and Bones / Q000276:immunology / Q000378:metabolism* / Q000502:physiology; D016207:Cytokines / Q000378:metabolism* / Q000502:physiology; D006023:Glycoproteins / Q000378:metabolism / Q000502:physiology; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism / Q000502:physiology; D007335:Insulin-Like Growth Factor II / Q000378:metabolism / Q000502:physiology; D007378:Interleukins / Q000378:metabolism / Q000502:physiology; D010006:Osteoblasts / Q000378:metabolism; D010010:Osteoclasts / Q000378:metabolism; D053244:Osteoprotegerin; D018121:Receptors, Cytokine / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D018160:Receptors, Cytoplasmic and Nuclear / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D018124:Receptors, Tumor Necrosis Factor; D016212:Transforming Growth Factor beta / Q000378:metabolism / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism / Q000502:physiology
D016207:Cytokines; D006023:Glycoproteins; D007378:Interleukins; D053244:Osteoprotegerin; D018121:Receptors, Cytokine; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human; D016212:Transforming Growth Factor beta; D014409:Tumor Necrosis Factor-alpha; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II